查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1448559

全球臨床試驗影像市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢和預測

Global Clinical Trial Imaging Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 286 Pages | 商品交期: 最快1-2個工作天內

價格

全球臨床試驗影像市場需求預計將從2023年的21.9億美元達到2032年近44.1億美元的市場規模，2024-2032年研究期間CAGR為8.09%。

臨床試驗影像涉及使用各種影像技術（例如 MRI、CT 和 PET）來評估和分析臨床試驗中的醫療狀況或治療結果。這些影像為研究人員和臨床醫生提供了有價值的資料，有助於評估治療效果、疾病進展和患者反應。

市場動態

臨床試驗影像市場的促進因素包括臨床試驗日益複雜、醫學影像技術的進步以及藥物開發中對客觀定量成像資料的需求。隨著製藥和生物技術公司尋求透過整合成像端點來提高臨床試驗的效率和準確性，該市場正在經歷成長。影像技術可以對疾病進展和治療反應進行非侵入性監測，促進早期決策並減少侵入性手術的需要。此外，監管機構擴大接受醫學影像作為臨床試驗中有價值的生物標記，這也有助於市場的擴張。精準醫學的興起和標靶治療的發展進一步推動了對影像技術的需求，以識別合適的患者族群。該市場也受到分散和虛擬臨床試驗採用的影響，其中成像在遠端監控和資料收集中至關重要，反映了臨床試驗方法不斷發展的模式。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球臨床試驗影像市場的每個細分市場進行包容性評估。臨床試驗成像產業的成長和趨勢為這項研究提供了整體方法。

市場區隔

臨床試驗影像市場報告的這一部分提供了國家和地區層面細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人口統計數據以及即將到來的機會。

按服務

  • 臨床試驗設計與諮詢服務
  • 閱讀與分析服務
  • 營運影像服務
  • 系統和技術支援服務
  • 專案和資料管理

按方式

  • CT檢查
  • 磁振造影
  • X光
  • 超音波
  • 光學相干斷層掃描 (OCT)
  • 其他

按應用

  • 非酒精性脂肪性肝炎
  • 慢性腎臟病
  • 糖尿病
  • 心血管疾病
  • 眼科
  • 肌肉骨骼
  • 腫瘤學
  • 胃腸病學
  • 兒科
  • 其他

按最終用途

  • 生物技術和製藥公司
  • 醫療器材製造商
  • 學術和政府研究機構
  • 合約研究組織 (CRO)
  • 其他

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲臨床試驗成像市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。臨床試驗成像市場的主要參與者包括 IXICO plc、Navitas Life Sciences、Resonance Health、ProScan Imaging、Radiant Sage LLC、Medpace、Biomedical Systems Corp、心血管成像技術、Intrinsic Imaging、BioTelemetry。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第1章：前言

  • 報告說明
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法論
    • 市場研究過程
    • 市場研究方法論

第 2 章：執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章：臨床試驗影像 - 產業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 產業動態
  • 波特五力分析
  • 市場吸引力分析
    • 按服務分類的市場吸引力分析
    • 按形式分類的市場吸引力分析
    • 市場吸引力分析：依應用分類
    • 按最終用途分類的市場吸引力分析
    • 市場吸引力分析：按地區

第 4 章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料廠商清單
    • 主要原物料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷通路發展趨勢

第 5 章：全球臨床試驗影像市場分析：按服務分類

  • 按服務概覽
  • 歷史和預測數據
  • 按服務分析
  • 臨床試驗設計與諮詢服務
  • 閱讀與分析服務
  • 營運影像服務
  • 系統和技術支援服務
  • 專案和資料管理

第 6 章：全球臨床試驗影像市場分析：按模式

  • 依方式概述
  • 歷史和預測數據
  • 按形態分析
  • CT檢查
  • 磁振造影
  • X光
  • 超音波
  • 光學相干斷層掃描 (OCT)
  • 其他

第 7 章：全球臨床試驗影像市場分析：按應用分類

  • 概述：按應用
  • 歷史和預測數據
  • 分析：按應用
  • 非酒精性脂肪性肝炎
  • 慢性腎臟病
  • 糖尿病
  • 心血管疾病
  • 眼科
  • 肌肉骨骼
  • 腫瘤學
  • 胃腸病學
  • 兒科
  • 其他

第 8 章：全球臨床試驗影像市場分析：依最終用途分類

  • 按最終用途分類的概述
  • 歷史和預測數據
  • 按最終用途分析
  • 生物技術和製藥公司
  • 醫療器材製造商
  • 學術和政府研究機構
  • 合約研究組織 (CRO)
  • 其他

第 9 章：全球臨床試驗影像市場分析：按地理位置

  • 區域展望
  • 介紹
  • 北美銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 北美按細分市場銷售分析
    • 北美按國家銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 歐洲按細分市場銷售分析
    • 歐洲按國家銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 亞太地區按細分市場銷售分析
    • 亞太地區國家/地區銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳洲銷售分析
    • 東南亞銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 拉丁美洲按細分市場銷售分析
    • 拉丁美洲按國家銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 中東和非洲按細分市場銷售分析
    • 中東和非洲國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東其他地區和非洲銷售分析

第 10 章：臨床試驗影像公司的競爭格局

  • 臨床試驗影像市場競爭
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他發展

第 11 章：公司簡介

  • 公司股份分析
  • 市場集中度
  • IXICO plc
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Navitas Life Sciences
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Resonance Health
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • ProScan Imaging
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Radiant Sage LLC
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Medpace
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Biomedical Systems Corp
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Cardiovascular Imaging Technologies
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Intrinsic Imaging
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • BioTelemetry
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展

註 - 在公司概況中，財務詳細資料和近期發展視情況而定，或者如果是私人公司，則可能不包括在內

Product Code: VMR112113786

The global demand for Clinical Trial Imaging Market is presumed to reach the market size of nearly USD 4.41 Billion by 2032 from USD 2.19 Billion in 2023 with a CAGR of 8.09% under the study period 2024 - 2032.

Clinical trial imaging involves the use of various imaging techniques, such as MRI, CTs, and PET, to assess and analyze medical conditions or treatment outcomes in clinical trials. These images provide valuable data for researchers and clinicians, aiding in the evaluation of treatment efficacy, disease progression, and patient response.

MARKET DYNAMICS

The clinical trial imaging market is driven by the increasing complexity of clinical trials, advancements in medical imaging technologies, and the demand for objective and quantitative imaging data in drug development. The market experiences growth as pharmaceutical and biotechnology companies seek to enhance the efficiency and accuracy of clinical trials by incorporating imaging endpoints. Imaging technologies allow for non-invasive monitoring of disease progression and treatment response, facilitating early decision-making and reducing the need for invasive procedures. Additionally, regulatory agencies' increasing acceptance of medical imaging as a valuable biomarker in clinical trials contributes to the market's expansion. The rise in precision medicine and the development of targeted therapies further drive the demand for imaging techniques to identify suitable patient populations. The market is also influenced by the adoption of decentralized and virtual clinical trials, where imaging is crucial in remote monitoring and data collection, reflecting the evolving landscape of clinical trial methodologies.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of clinical trial imaging. The growth and trends of clinical trial imaging industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the clinical trial imaging market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Service

  • Clinical Trial Design And Consultation Services
  • Reading And Analytical Services
  • Operational Imaging Services
  • System And Technology Support Services
  • Project And Data Management

By Modality

  • Computed Tomography
  • Magnetic Resonance Imaging
  • X-Ray
  • Ultrasound
  • Optical Coherence Tomography (OCT)
  • Others

By Application

  • NASH
  • CKD
  • Diabetes
  • Cardiovascular Diseases
  • Ophthalmology
  • Musculoskeletal
  • Oncology
  • Gastroenterology
  • Pediatrics
  • Others

By End Use

  • Biotechnology And Pharmaceutical Companies
  • Medical Devices Manufacturers
  • Academic And Government Research Institutes
  • Contract Research Organizations (CROs)
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Clinical Trial Imaging market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Clinical Trial Imaging market include IXICO plc, Navitas Life Sciences, Resonance Health, ProScan Imaging, Radiant Sage LLC, Medpace, Biomedical Systems Corp, Cardiovascular Imaging Technologies, Intrinsic Imaging, BioTelemetry. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . CLINICAL TRIAL IMAGING - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Service
    • 3.7.2 Market Attractiveness Analysis By Modality
    • 3.7.3 Market Attractiveness Analysis By Application
    • 3.7.4 Market Attractiveness Analysis By End Use
    • 3.7.5 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL CLINICAL TRIAL IMAGING MARKET ANALYSIS BY SERVICE

  • 5.1 Overview by Service
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Service
  • 5.4 Clinical Trial Design And Consultation Services Historic and Forecast Sales by Regions
  • 5.5 Reading And Analytical Services Historic and Forecast Sales by Regions
  • 5.6 Operational Imaging Services Historic and Forecast Sales by Regions
  • 5.7 System And Technology Support Services Historic and Forecast Sales by Regions
  • 5.8 Project And Data Management Historic and Forecast Sales by Regions

6 . GLOBAL CLINICAL TRIAL IMAGING MARKET ANALYSIS BY MODALITY

  • 6.1 Overview by Modality
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Modality
  • 6.4 Computed Tomography Historic and Forecast Sales by Regions
  • 6.5 Magnetic Resonance Imaging Historic and Forecast Sales by Regions
  • 6.6 X-Ray Historic and Forecast Sales by Regions
  • 6.7 Ultrasound Historic and Forecast Sales by Regions
  • 6.8 Optical Coherence Tomography (OCT) Historic and Forecast Sales by Regions
  • 6.9 Others Historic and Forecast Sales by Regions

7 . GLOBAL CLINICAL TRIAL IMAGING MARKET ANALYSIS BY APPLICATION

  • 7.1 Overview by Application
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Application
  • 7.4 NASH Historic and Forecast Sales by Regions
  • 7.5 CKD Historic and Forecast Sales by Regions
  • 7.6 Diabetes Historic and Forecast Sales by Regions
  • 7.7 Cardiovascular Diseases Historic and Forecast Sales by Regions
  • 7.8 Ophthalmology Historic and Forecast Sales by Regions
  • 7.9 Musculoskeletal Historic and Forecast Sales by Regions
  • 7.10. Oncology Historic and Forecast Sales by Regions
  • 7.11 Gastroenterology Historic and Forecast Sales by Regions
  • 7.12 Pediatrics Historic and Forecast Sales by Regions
  • 7.13 Others Historic and Forecast Sales by Regions

8 . GLOBAL CLINICAL TRIAL IMAGING MARKET ANALYSIS BY END USE

  • 8.1 Overview by End Use
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by End Use
  • 8.4 Biotechnology And Pharmaceutical Companies Historic and Forecast Sales by Regions
  • 8.5 Medical Devices Manufacturers Historic and Forecast Sales by Regions
  • 8.6 Academic And Government Research Institutes Historic and Forecast Sales by Regions
  • 8.7 Contract Research Organizations (CROs) Historic and Forecast Sales by Regions
  • 8.8 Others Historic and Forecast Sales by Regions

9 . GLOBAL CLINICAL TRIAL IMAGING MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2. North America By Segment Sales Analysis
    • 9.3.3. North America By Country Sales Analysis
    • 9.3.4. United State Sales Analysis
    • 9.3.5. Canada Sales Analysis
    • 9.3.6. Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2. Europe by Segment Sales Analysis
    • 9.4.3. Europe by Country Sales Analysis
    • 9.4.4. United Kingdom Sales Analysis
    • 9.4.5. France Sales Analysis
    • 9.4.6. Germany Sales Analysis
    • 9.4.7. Italy Sales Analysis
    • 9.4.8. Russia Sales Analysis
    • 9.4.9. Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2. Asia Pacific by Segment Sales Analysis
    • 9.5.3. Asia Pacific by Country Sales Analysis
    • 9.5.4. China Sales Analysis
    • 9.5.5. India Sales Analysis
    • 9.5.6. Japan Sales Analysis
    • 9.5.7. South Korea Sales Analysis
    • 9.5.8. Australia Sales Analysis
    • 9.5.9. South East Asia Sales Analysis
    • 9.5.10. Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2. Latin America by Segment Sales Analysis
    • 9.6.3. Latin America by Country Sales Analysis
    • 9.6.4. Brazil Sales Analysis
    • 9.6.5. Argentina Sales Analysis
    • 9.6.6. Peru Sales Analysis
    • 9.6.7. Chile Sales Analysis
    • 9.6.8. Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2. Middle East & Africa by Segment Sales Analysis
    • 9.7.3. Middle East & Africa by Country Sales Analysis
    • 9.7.4. Saudi Arabia Sales Analysis
    • 9.7.5. UAE Sales Analysis
    • 9.7.6. Israel Sales Analysis
    • 9.7.7. South Africa Sales Analysis
    • 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE CLINICAL TRIAL IMAGING COMPANIES

  • 10.1. Clinical Trial Imaging Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11 . COMPANY PROFILES OF CLINICAL TRIAL IMAGING INDUSTRY

  • 11.1. Company Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. IXICO plc
    • 11.3.1. Company Overview
    • 11.3.2. Company Revenue
    • 11.3.3. Products
    • 11.3.4. Recent Developments
  • 11.4. Navitas Life Sciences
    • 11.4.1. Company Overview
    • 11.4.2. Company Revenue
    • 11.4.3. Products
    • 11.4.4. Recent Developments
  • 11.5. Resonance Health
    • 11.5.1. Company Overview
    • 11.5.2. Company Revenue
    • 11.5.3. Products
    • 11.5.4. Recent Developments
  • 11.6. ProScan Imaging
    • 11.6.1. Company Overview
    • 11.6.2. Company Revenue
    • 11.6.3. Products
    • 11.6.4. Recent Developments
  • 11.7. Radiant Sage LLC
    • 11.7.1. Company Overview
    • 11.7.2. Company Revenue
    • 11.7.3. Products
    • 11.7.4. Recent Developments
  • 11.8. Medpace
    • 11.8.1. Company Overview
    • 11.8.2. Company Revenue
    • 11.8.3. Products
    • 11.8.4. Recent Developments
  • 11.9. Biomedical Systems Corp
    • 11.9.1. Company Overview
    • 11.9.2. Company Revenue
    • 11.9.3. Products
    • 11.9.4. Recent Developments
  • 11.10. Cardiovascular Imaging Technologies
    • 11.10.1. Company Overview
    • 11.10.2. Company Revenue
    • 11.10.3. Products
    • 11.10.4. Recent Developments
  • 11.11. Intrinsic Imaging
    • 11.11.1. Company Overview
    • 11.11.2. Company Revenue
    • 11.11.3. Products
    • 11.11.4. Recent Developments
  • 11.12. BioTelemetry
    • 11.12.1. Company Overview
    • 11.12.2. Company Revenue
    • 11.12.3. Products
    • 11.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Service (USD MN)
  • Clinical Trial Design And Consultation Services Market Sales by Geography (USD MN)
  • Reading And Analytical Services Market Sales by Geography (USD MN)
  • Operational Imaging Services Market Sales by Geography (USD MN)
  • System And Technology Support Services Market Sales by Geography (USD MN)
  • Project And Data Management Market Sales by Geography (USD MN)
  • Analysis Market by Modality (USD MN)
  • Computed Tomography Market Sales by Geography (USD MN)
  • Magnetic Resonance Imaging Market Sales by Geography (USD MN)
  • X-Ray Market Sales by Geography (USD MN)
  • Ultrasound Market Sales by Geography (USD MN)
  • Optical Coherence Tomography (OCT) Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis by Application (USD MN)
  • NASH Market Sales by Geography (USD MN)
  • CKD Market Sales by Geography (USD MN)
  • Diabetes Market Sales by Geography (USD MN)
  • Cardiovascular Diseases Market Sales by Geography (USD MN)
  • Ophthalmology Market Sales by Geography (USD MN)
  • Musculoskeletal Market Sales by Geography (USD MN)
  • Oncology Market Sales by Geography (USD MN)
  • Gastroenterology Market Sales by Geography (USD MN)
  • Pediatrics Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis by End Use (USD MN)
  • Biotechnology And Pharmaceutical Companies Market Sales by Geography (USD MN)
  • Medical Devices Manufacturers Market Sales by Geography (USD MN)
  • Academic And Government Research Institutes Market Sales by Geography (USD MN)
  • Contract Research Organizations (CROs) Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Clinical Trial Imaging Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Clinical Trial Imaging Report
  • Market Research Process
  • Market Research Methodology
  • Global Clinical Trial Imaging Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Service
  • Market Attractiveness Analysis by Modality
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by End Use
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Service (USD MN)
  • Clinical Trial Design And Consultation Services Market Sales by Geography (USD MN)
  • Reading And Analytical Services Market Sales by Geography (USD MN)
  • Operational Imaging Services Market Sales by Geography (USD MN)
  • System And Technology Support Services Market Sales by Geography (USD MN)
  • Project And Data Management Market Sales by Geography (USD MN)
  • Global Market Analysis by Modality (USD MN)
  • Computed Tomography Market Sales by Geography (USD MN)
  • Magnetic Resonance Imaging Market Sales by Geography (USD MN)
  • X-Ray Market Sales by Geography (USD MN)
  • Ultrasound Market Sales by Geography (USD MN)
  • Optical Coherence Tomography (OCT) Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by Application (USD MN)
  • NASH Market Sales by Geography (USD MN)
  • CKD Market Sales by Geography (USD MN)
  • Diabetes Market Sales by Geography (USD MN)
  • Cardiovascular Diseases Market Sales by Geography (USD MN)
  • Ophthalmology Market Sales by Geography (USD MN)
  • Musculoskeletal Market Sales by Geography (USD MN)
  • Oncology Market Sales by Geography (USD MN)
  • Gastroenterology Market Sales by Geography (USD MN)
  • Pediatrics Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by End Use (USD MN)
  • Biotechnology And Pharmaceutical Companies Market Sales by Geography (USD MN)
  • Medical Devices Manufacturers Market Sales by Geography (USD MN)
  • Academic And Government Research Institutes Market Sales by Geography (USD MN)
  • Contract Research Organizations (CROs) Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.